Medipharm Labs and Cronos Group Sign Second Manufacturing Agreement

Medipharm Labs (TSX: LABS) and Cronos Group (TSX: CRON) (NASDAQ: CRON) have entered into their second manufacturing agreement of the year. Under the new multi year agreement, Medipharm is to fill and pack vaporizor devices for Cronos Group’s recreational brand Cove, pending approval from Health Canada.

The white label agreement is for a term of two years with an option for renewal. However little details were provided by the two firms, with no indication as to the anticipated dollar value of the transaction, whether it was an exclusive transaction, or how many devices are anticipated to be filled and packaged by Medipharm Labs on an annual basis.

By leveraging our specialized expertise, technology and industrial scale vape filling capabilities, we will assist Cronos Group in delivering high quality, purity assured and Health Canada approved, derivative products further advancing their industry leading reputation and enhancing the supply chain in this important new category.

Pat McCutcheon, CEO of MediPharm Labs

The lack of details for the recently signed manufacturing agreement is in stark contrast to the agreement announced in May, which is for an anticipated $30 million over the first 18 months. That agreement has the option to expand to $60 million via certain renewal and purchase options included within the transaction. The initial manufacturing agreement was for bulk resin supply as well as tolling.

The latest agreement is subject to Health Canada’s approved of the “recreation 2.0” vaporizer devices.

Medipharm Labs closed yesterdays session at $4.93 on the Toronto Stock Exchange.


Information for this briefing was found via Sedar, Medipharm Labs and Cronos Group. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why $50 Silver, $4000 Gold Might Be Closer Than Anyone Thinks | Bradley Langille – GoGold Resources

Why Silver’s True Price Could Be Much Higher | Joaquín Marias – Argenta Silver

Gold Enters A ‘Stronger For Longer’ Phase | Richard Young – i-80 Gold

Recommended

Emerita Resources Intersects Further Mineralization At El Cura, Expanding Deposit

ESGold Sees ANT Survey Reveal Vertically Continuous System To 1,200 Metres Depth

Related News

Cronos: Raymond James Reiterates Price Target After PharmaCann Investment

Yesterday, Cronos Group (TSX: CRON) showed once again that the demand for U.S cannabis assets...

Tuesday, June 15, 2021, 05:50:00 PM

Cronos Group Begins Commercial Production Of CBG Under Modified Ginkgo Agreement

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning announced that it has amended its collaboration...

Friday, June 4, 2021, 07:50:22 AM

Cronos Group Sees Revenues Stay Flat In First Quarter Versus Q4, Margins Improve

Cronos Group (TSX: CRON) this morning posted its first quarter financial results for 2022. Surprisingly,...

Tuesday, May 10, 2022, 07:53:11 AM

MediPharm Labs Posts Q3 Revenues of $5.4 Million, Continues To Post Negative Gross Margins

MediPharm Labs (TSX: LABS) this morning reported its third quarter financial results, posting revenues of...

Monday, November 15, 2021, 08:54:23 AM

Canadian Cannabis: Canaccord Lifts Cronos Target, Reiterates Canopy Growth And Tilray Ratings

Yesterday Canaccord Genuity Capital Markets put out a second-quarter preview note on the top Canadian...

Thursday, July 28, 2022, 03:02:00 PM